Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novabay Pharmaceuticals | B9P | Nov 15, 2024 | 2.80 | 0.00 |
Novacyt | NYZ | Nov 15, 2024 | 0.58 | -3.36 |
Novagold Resources Inc. | NGR | Nov 15, 2024 | 3.12 | +0.97 |
Novanta Inc. - | 1GSN | Nov 15, 2024 | 160.00 | -0.62 |
Novartis AG | NOTA | Nov 15, 2024 | 95.60 | -3.82 |
Novavax, Inc. | NVV1 | Nov 15, 2024 | 6.76 | -3.41 |
Novem Group S.A. | NVM | Nov 15, 2024 | 5.52 | +4.55 |
NOVINA S.A. E ZY 1,16 | T36 | Nov 15, 2024 | 0.24 | -7.28 |
Novo Nordisk A/S | NOVA | Nov 15, 2024 | 96.60 | -3.40 |
Novo Resources Corp | 1NOR | Nov 15, 2024 | 0.05 | 0.00 |
NovoCure Limited - Ordinary Shares | 038 | Nov 15, 2024 | 15.59 | -6.87 |
NOVONIX ADR | GC30 | Nov 15, 2024 | 1.82 | -0.55 |
Novonix Limited | GC3 | Nov 15, 2024 | 0.49 | +3.95 |
NOVOTEK AB B SK-,25 | Z9D | Nov 15, 2024 | 5.82 | 0.00 |
Novozymes AS | NZM | Nov 15, 2024 | 53.00 | -0.93 |
Novozymes B | NZM2 | Nov 15, 2024 | 53.34 | -1.44 |
Novra Technologies Inc. | 7CV | Nov 15, 2024 | 0.05 | 0.00 |
Novus Holdings Limited | N09 | Nov 15, 2024 | 0.39 | -3.98 |
NOW Inc. | 11N | Nov 15, 2024 | 13.30 | -5.00 |
NP3 Fastigheter | N33 | Nov 15, 2024 | 21.10 | -0.47 |
NPC Inc | 59N | Nov 15, 2024 | 5.25 | +0.96 |
NRC Group | 8NR | Nov 15, 2024 | 0.24 | -2.87 |
NRG Energy Inc. | NRA | Nov 15, 2024 | 85.88 | -1.20 |
NRJ Group | NR8 | Nov 15, 2024 | 6.92 | -2.54 |
NRW Holdings Limited | 3NR | Nov 15, 2024 | 2.30 | -0.86 |
Ns United Kaiun Kaisha, Ltd. | 8WN | Nov 15, 2024 | 24.00 | +0.84 |
NSE SA | 7YM | Nov 15, 2024 | 29.00 | +0.35 |
NSI N.V. | N4RN | Nov 15, 2024 | 19.50 | 0.00 |
NSJ Gold Corp | 9PZ | Nov 15, 2024 | 0.02 | 0.00 |
NSK Ltd. | NSK | Nov 15, 2024 | 3.98 | -1.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.